Quick Answer
60 DEGREES PHARMACEUTICALS, INC. reported Stockholders Equity of $3.46 million for fiscal year 2025.
60 DEGREES PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $3.46M | -14.2% |
| 2024 | $4.04M | -17.1% |
| 2023 | $4.87M | +120.7% |
| 2022 | -$23.58M | -29.9% |
| 2021 | -$18.15M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.43M | -26.6% | +82.4% |
| June 30, 2025 | $2.43M | -20.0% | -40.9% |
| March 31, 2025 | $4.11M | -42.9% | +1.8% |
| December 31, 2024 | $4.04M | -17.1% | -33.2% |
| September 30, 2024 | $6.04M | -7.3% | +99.0% |
| June 30, 2024 | $3.04M | +113.6% | -57.8% |
| March 31, 2024 | $7.20M | +133.7% | +47.8% |
| December 31, 2023 | $4.87M | +120.7% | -25.3% |
- 60 DEGREES PHARMACEUTICALS, INC. showed a decrease of -14.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2025 period, 60 DEGREES PHARMACEUTICALS, INC.’s stockholders equity has grown by 119.1% (from -$18.15 million to $3.46 million).
- The most recent figure is from 60 DEGREES PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: